anaplastic lymphoma kinase gene rearranged non-small-cell lung
A fusion protein resulting from the rearrangement of the EML4 gene with the ALK gene, present in approximately 5% of non-small-cell lung cancers, primarily adenocarcinomas. This fusion protein is a target of ALK tyrosine kinase inhibitors in the treatment of these tumors.
Search Stedman's Medical Dictionary
Examples: glitazone, GI cocktail, etc.